Blog

Investors might want to bet on Texas Instruments (TXN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

NovoCure (NVCR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices

S&T Bancorp (STBA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Hanover Insurance Group (THG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces

Masco Corporation MAS is scheduled to report its second-quarter 2026 results on July 29, before the opening bell.In the last reported quarter, the company’s adjusted earnings and net sales beat the

Flex Ltd. FLEX is slated to report first-quarter fiscal 2027 results on Wednesday, before market open.

The Zacks Consensus Estimate for fiscal first-quarter revenues is $7.58 billion, which

Investors in Park Hotels & Resorts Inc. PK need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $2.50 Call had some of the highest

International Paper Company IP is scheduled to report second-quarter 2026 results on July 30, 2026, before the opening bell.

The Zacks Consensus Estimate for IP’s second-quarter revenues is pegged

Immunocore Holdings IMCR is trying to move beyond the profile of a one-product rare-cancer company. Kimmtrak remains its commercial anchor, but the broader story is increasingly about the company’s

MasTec, Inc. MTZ is scheduled to report second-quarter 2026 results on July 30, after the closing bell.In the last reported quarter, its earnings and revenues surpassed the Zacks Consensus Estimate

Willis Towers Watson Public Limited Company WTW is expected to register an improvement in both top and bottom lines when it reports second-quarter 2026 results on July 30, before the opening

The Zacks Industrial Products sector kicked off the second quarter of 2026 earnings season last week. In the quarter, the sector is anticipated to have benefited from the solid momentum in the

Immunocore Holdings IMCR gives investors a mixed setup. Kimmtrak sales are still growing, the balance sheet is substantial and the pipeline has several value-creating shots on goal.

The caution is

Immunocore Holdings IMCR has built its commercial base around Kimmtrak, its only marketed product and a standard treatment for eligible metastatic uveal melanoma patients in most launched markets.

Darling Ingredients Inc. DAR is becoming less dependent on traditional rendering economics as collagen, specialty nutrition and renewable fuels take larger roles in its earnings mix.The shift offers

Google Smashes EPS, Stock Falls

Last week, Zacks Rank #2 (Buy) company Alphabet (GOOGL) reported financial results that smashed Wall Street expectations. Total revenue jumped to ~$120 billion,

Darling Ingredients Inc. DAR has a better operating story after a sharp first-quarter recovery, but the case is mixed.The shares combine stronger earnings, a discounted forward multiple and

The Hershey Company HSY is likely to witness top-line growth when it reports second-quarter 2026 earnings on July 30, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at

Continued improved pricing, exposure growth, portfolio streamlining, solid retention, renewals, reinsurance agreements and accelerated digitalization are expected to have enhanced insurance stocks’

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of